Caitlin Cronin
Stock Analyst at Canaccord Genuity
(1.75)
# 2,875
Out of 4,810 analysts
24
Total ratings
26.32%
Success rate
-4.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Caitlin Cronin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TELA TELA Bio | Maintains: Buy | $12 → $7 | $1.00 | +600.00% | 4 | Mar 21, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $27 | $26.03 | +3.73% | 1 | Mar 17, 2025 | |
| BVS Bioventus | Maintains: Buy | $15 | $7.74 | +93.80% | 1 | Mar 17, 2025 | |
| AXGN Axogen | Maintains: Buy | $22 → $26 | $15.65 | +66.13% | 4 | Feb 26, 2025 | |
| VCEL Vericel | Maintains: Buy | $64 → $67 | $42.02 | +59.47% | 3 | Feb 3, 2025 | |
| KRMD KORU Medical Systems | Maintains: Buy | $3 → $4 | $2.40 | +66.67% | 2 | Nov 14, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 | $9.91 | +101.82% | 3 | Aug 30, 2024 | |
| INMD InMode | Maintains: Hold | $21 → $16 | $15.41 | +3.86% | 2 | Jul 12, 2024 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Hold | $130 | $97.27 | +33.65% | 1 | Feb 23, 2024 | |
| ENOV Enovis | Maintains: Buy | $73 → $75 | $31.48 | +138.25% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $79 | $72.35 | +9.19% | 1 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $270 → $12 | $5.74 | +109.06% | 1 | Nov 14, 2023 |
TELA Bio
Mar 21, 2025
Maintains: Buy
Price Target: $12 → $7
Current: $1.00
Upside: +600.00%
Smith & Nephew
Mar 17, 2025
Maintains: Hold
Price Target: $27
Current: $26.03
Upside: +3.73%
Bioventus
Mar 17, 2025
Maintains: Buy
Price Target: $15
Current: $7.74
Upside: +93.80%
Axogen
Feb 26, 2025
Maintains: Buy
Price Target: $22 → $26
Current: $15.65
Upside: +66.13%
Vericel
Feb 3, 2025
Maintains: Buy
Price Target: $64 → $67
Current: $42.02
Upside: +59.47%
KORU Medical Systems
Nov 14, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.40
Upside: +66.67%
Alphatec Holdings
Aug 30, 2024
Maintains: Buy
Price Target: $20
Current: $9.91
Upside: +101.82%
InMode
Jul 12, 2024
Maintains: Hold
Price Target: $21 → $16
Current: $15.41
Upside: +3.86%
Zimmer Biomet Holdings
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $97.27
Upside: +33.65%
Enovis
Feb 23, 2024
Maintains: Buy
Price Target: $73 → $75
Current: $31.48
Upside: +138.25%
Feb 21, 2024
Reiterates: Buy
Price Target: $79
Current: $72.35
Upside: +9.19%
Nov 14, 2023
Downgrades: Hold
Price Target: $270 → $12
Current: $5.74
Upside: +109.06%